No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1gztD, 1.0000, 0.00, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE
2, 2vucD, 0.9997, 0.06, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
3, 2bp6C, 0.9996, 0.07, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH A-L-GALACTOPYRANOSIDE
4, 2jdnD, 0.9995, 0.08, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-MANNOPYRANOSIDE
5, 2jdkD, 0.9995, 0.08, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
6, 1uzvD, 0.9995, 0.08, 1.000, 114, 114, HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX
7, 4ce8A, 0.9994, 0.09, 1.000, 114, 114, PERDEUTERATED PSEUDOMONAS AERUGINOSA LECTIN II COMPLEX WITH HYDROGENATED L-FUCOSE AND CALCIUM
8, 2jdhD, 0.9994, 0.09, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
9, 5nf0D, 0.9991, 0.12, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
10, 2jdmD, 0.9991, 0.12, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
11, 3zdvA, 0.9990, 0.12, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(246-TRIMETHYLPHENYLSULFONYLAMIDO)- 6-DEOXY-ALPHA-D-MANNOPYRANOSIDE
12, 2vudD, 0.9987, 0.14, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
13, 1w8hA, 0.9987, 0.14, 1.000, 114, 114, STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE
14, 5nesA, 0.9986, 0.14, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
15, 5nf0B, 0.9985, 0.15, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
16, 5nesB, 0.9985, 0.15, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
17, 5nesD, 0.9984, 0.16, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
18, 5i8xC, 0.9984, 0.16, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
19, 3zdvC, 0.9984, 0.16, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(246-TRIMETHYLPHENYLSULFONYLAMIDO)- 6-DEOXY-ALPHA-D-MANNOPYRANOSIDE
20, 5i8xB, 0.9983, 0.16, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
21, 5i8mA, 0.9983, 0.16, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
22, 1w8hD, 0.9983, 0.16, 1.000, 114, 114, STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE
23, 5i8xA, 0.9982, 0.17, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
24, 5i8mC, 0.9982, 0.16, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
25, 5neyC, 0.9981, 0.17, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
26, 5d2aB, 0.9981, 0.17, 1.000, 114, 114, BIFUNCTIONAL DENDRIMERS
27, 2jdnC, 0.9981, 0.17, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-MANNOPYRANOSIDE
28, 2jdkC, 0.9981, 0.17, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
29, 2bojC, 0.9981, 0.17, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH METHYL-B-D-ARABINOPYRANOSIDE
30, 1uzvC, 0.9981, 0.17, 1.000, 114, 114, HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX
31, 1ovpA, 0.9981, 0.17, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FRUCTOSE
32, 1ourA, 0.9981, 0.17, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH MANNOSE
33, 5i8xD, 0.9980, 0.17, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
34, 5i8mD, 0.9980, 0.18, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
35, 3zdvD, 0.9980, 0.17, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(246-TRIMETHYLPHENYLSULFONYLAMIDO)- 6-DEOXY-ALPHA-D-MANNOPYRANOSIDE
36, 5a3oC, 0.9979, 0.18, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(CINNAMIDO)-6-DEOXY- ALPHA-D-MANNOPYRANOSIDE AT 1.6 ANSGTROM
37, 2jdpD, 0.9979, 0.18, 0.991, 114, 114, MUTANT (S23A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
38, 2bp6B, 0.9979, 0.18, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH A-L-GALACTOPYRANOSIDE
39, 1oxcC, 0.9979, 0.18, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FUCOSE
40, 5neyD, 0.9978, 0.18, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
41, 5mazB, 0.9978, 0.18, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-THIOPHENESULFONAMIDE-25-DIMETHYL-N-METHYL-BETA-L- FUCOPYRANOSIDE
42, 5i8mB, 0.9978, 0.18, 1.000, 114, 114, BICYCLIC ANTIMIBROCIAL PEPTIDES
43, 5d2aA, 0.9978, 0.18, 1.000, 114, 114, BIFUNCTIONAL DENDRIMERS
44, 3zdvB, 0.9978, 0.18, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(246-TRIMETHYLPHENYLSULFONYLAMIDO)- 6-DEOXY-ALPHA-D-MANNOPYRANOSIDE
45, 2bp6D, 0.9978, 0.18, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH A-L-GALACTOPYRANOSIDE
46, 1w8fA, 0.9978, 0.19, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV)
47, 1gztC, 0.9978, 0.19, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE
48, 5a6zA, 0.9977, 0.19, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A
49, 2vucC, 0.9977, 0.19, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
50, 2jdhC, 0.9977, 0.19, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
51, 5a3oA, 0.9976, 0.19, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(CINNAMIDO)-6-DEOXY- ALPHA-D-MANNOPYRANOSIDE AT 1.6 ANSGTROM
52, 2jduC, 0.9976, 0.19, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
53, 2bojD, 0.9976, 0.19, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH METHYL-B-D-ARABINOPYRANOSIDE
54, 1oxcD, 0.9976, 0.19, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FUCOSE
55, 5a6yA, 0.9975, 0.20, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA13MANNOSIDE
56, 2jdpB, 0.9975, 0.20, 0.991, 114, 114, MUTANT (S23A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
57, 1gztB, 0.9975, 0.19, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE
58, 5ngqB, 0.9974, 0.20, 1.000, 114, 114, BICYCLIC ANTIMICROBIAL PEPTIDES
59, 5ngqA, 0.9974, 0.20, 1.000, 114, 114, BICYCLIC ANTIMICROBIAL PEPTIDES
60, 5nesC, 0.9974, 0.20, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
61, 2jdkB, 0.9974, 0.20, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
62, 2bojB, 0.9974, 0.20, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH METHYL-B-D-ARABINOPYRANOSIDE
63, 5mazD, 0.9973, 0.20, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-THIOPHENESULFONAMIDE-25-DIMETHYL-N-METHYL-BETA-L- FUCOPYRANOSIDE
64, 5a6yB, 0.9973, 0.21, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA13MANNOSIDE
65, 2jdmC, 0.9973, 0.20, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
66, 2jdmB, 0.9973, 0.20, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
67, 1uzvB, 0.9973, 0.20, 1.000, 114, 114, HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX
68, 5nf0A, 0.9972, 0.21, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
69, 5a6qB, 0.9972, 0.21, 0.868, 114, 114, NATIVE STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14
70, 1w8fC, 0.9972, 0.21, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV)
71, 5ngqC, 0.9971, 0.21, 1.000, 114, 114, BICYCLIC ANTIMICROBIAL PEPTIDES
72, 5a6qA, 0.9971, 0.21, 0.868, 114, 114, NATIVE STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14
73, 2jdhB, 0.9971, 0.21, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
74, 2bojA, 0.9971, 0.21, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH METHYL-B-D-ARABINOPYRANOSIDE
75, 1w8hC, 0.9971, 0.21, 1.000, 114, 114, STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE
76, 1w8fD, 0.9971, 0.21, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV)
77, 1w8fB, 0.9971, 0.21, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV)
78, 1ouxC, 0.9971, 0.21, 1.000, 114, 114, LECB (PA-LII) SUGAR-FREE
79, 5a6yD, 0.9970, 0.21, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA13MANNOSIDE
80, 5a6qD, 0.9970, 0.21, 0.868, 114, 114, NATIVE STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14
81, 2vudC, 0.9970, 0.22, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
82, 2vucB, 0.9970, 0.21, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
83, 2jdyC, 0.9970, 0.21, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-B-D-MANNOYRANOSIDE
84, 5a70B, 0.9969, 0.22, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE
85, 1oxcB, 0.9969, 0.22, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FUCOSE
86, 5ngqD, 0.9968, 0.22, 1.000, 114, 114, BICYCLIC ANTIMICROBIAL PEPTIDES
87, 5mb1B, 0.9968, 0.22, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 246-TRIMETHYLPHENYLSULFONAMIDE-N-METHYL-L- FUCOPYRANOSIDE
88, 5mb1A, 0.9968, 0.22, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 246-TRIMETHYLPHENYLSULFONAMIDE-N-METHYL-L- FUCOPYRANOSIDE
89, 5neyA, 0.9967, 0.22, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
90, 5a6zC, 0.9967, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A
91, 5a6yC, 0.9967, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA13MANNOSIDE
92, 5a6xB, 0.9967, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
93, 2jdnB, 0.9967, 0.22, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-MANNOPYRANOSIDE
94, 1w8hB, 0.9967, 0.23, 1.000, 114, 114, STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE
95, 1ovsC, 0.9967, 0.23, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE
96, 5nf0C, 0.9966, 0.23, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
97, 5mazC, 0.9966, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-THIOPHENESULFONAMIDE-25-DIMETHYL-N-METHYL-BETA-L- FUCOPYRANOSIDE
98, 5mayB, 0.9966, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-THIOPHENESULFONAMIDE-N-(BETA-L-FUCOPYRANOSYL METHYL)
99, 2jdyB, 0.9966, 0.23, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-B-D-MANNOYRANOSIDE
100, 2jdyA, 0.9966, 0.23, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-B-D-MANNOYRANOSIDE
101, 5a6zB, 0.9965, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A
102, 5a6qC, 0.9965, 0.23, 0.868, 114, 114, NATIVE STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14
103, 3dcqD, 0.9965, 0.23, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH THE SYNTHETIC LIGAND 2G0
104, 5mb1D, 0.9964, 0.23, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 246-TRIMETHYLPHENYLSULFONAMIDE-N-METHYL-L- FUCOPYRANOSIDE
105, 5a70C, 0.9964, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE
106, 4ut5A, 0.9964, 0.24, 0.904, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE
107, 2vudB, 0.9964, 0.24, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
108, 2jdpC, 0.9964, 0.24, 0.991, 114, 114, MUTANT (S23A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
109, 1ovsB, 0.9964, 0.24, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE
110, 1ouxB, 0.9964, 0.23, 1.000, 114, 114, LECB (PA-LII) SUGAR-FREE
111, 5mayD, 0.9963, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-THIOPHENESULFONAMIDE-N-(BETA-L-FUCOPYRANOSYL METHYL)
112, 5a6xD, 0.9963, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
113, 5a6xC, 0.9962, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
114, 4ut5D, 0.9962, 0.24, 0.904, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE
115, 3dcqB, 0.9962, 0.24, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH THE SYNTHETIC LIGAND 2G0
116, 5a6xA, 0.9961, 0.24, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
117, 3dcqC, 0.9961, 0.25, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH THE SYNTHETIC LIGAND 2G0
118, 2jduA, 0.9961, 0.25, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
119, 2jdpA, 0.9961, 0.25, 0.991, 114, 114, MUTANT (S23A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
120, 1ouxD, 0.9961, 0.24, 1.000, 114, 114, LECB (PA-LII) SUGAR-FREE
121, 5a6zD, 0.9960, 0.25, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A
122, 1ovsD, 0.9959, 0.25, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE
123, 5a70D, 0.9958, 0.26, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE
124, 5a3oB, 0.9957, 0.26, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(CINNAMIDO)-6-DEOXY- ALPHA-D-MANNOPYRANOSIDE AT 1.6 ANSGTROM
125, 4ut5B, 0.9957, 0.26, 0.904, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE
126, 2jdyD, 0.9957, 0.26, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-B-D-MANNOYRANOSIDE
127, 1gztA, 0.9956, 0.28, 1.000, 114, 114, PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE
128, 4ut5C, 0.9955, 0.26, 0.904, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE
129, 1uzvA, 0.9955, 0.29, 1.000, 114, 114, HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX
130, 2jduB, 0.9954, 0.27, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
131, 2jdkA, 0.9954, 0.29, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
132, 5neyB, 0.9953, 0.27, 1.000, 114, 114, DISCOVERY CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED DL-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA
133, 5a3oD, 0.9953, 0.28, 1.000, 114, 114, CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH METHYL 6-(CINNAMIDO)-6-DEOXY- ALPHA-D-MANNOPYRANOSIDE AT 1.6 ANSGTROM
134, 2jdhA, 0.9953, 0.29, 1.000, 114, 114, LECTIN PA-IIL OF P.AERUGINOSA COMPLEXED WITH DISACCHARIDE DERIVATIVE
135, 2bp6A, 0.9952, 0.29, 1.000, 114, 114, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN (PA-IIL) COMPLEXED WITH A-L-GALACTOPYRANOSIDE
136, 2vucA, 0.9949, 0.31, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
137, 2jdnA, 0.9949, 0.31, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-MANNOPYRANOSIDE
138, 1ovsA, 0.9949, 0.28, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE
139, 4ce8D, 0.9947, 0.31, 1.000, 114, 114, PERDEUTERATED PSEUDOMONAS AERUGINOSA LECTIN II COMPLEX WITH HYDROGENATED L-FUCOSE AND CALCIUM
140, 2jdmA, 0.9947, 0.31, 0.991, 114, 114, MUTANT (S22A) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
141, 5hchA, 0.9946, 0.29, 1.000, 114, 114, X-RAY STRUCTURE OF A LECTIN-BOUND DNA DUPLEX CONTAINING AN UNNATURAL PHENANTHRENYL PAIR
142, 2jduD, 0.9944, 0.31, 0.991, 114, 114, MUTANT (G24N) OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH METHYL-A-L-FUCOPYRANOSIDE
143, 1ousB, 0.9943, 0.30, 1.000, 114, 114, LECB (PA-LII) CALCIUM-FREE
144, 1oxcA, 0.9942, 0.30, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH FUCOSE
145, 3dcqA, 0.9938, 0.32, 1.000, 114, 114, LECB (PA-LII) IN COMPLEX WITH THE SYNTHETIC LIGAND 2G0
146, 4ce8B, 0.9937, 0.33, 1.000, 114, 114, PERDEUTERATED PSEUDOMONAS AERUGINOSA LECTIN II COMPLEX WITH HYDROGENATED L-FUCOSE AND CALCIUM
147, 2vudA, 0.9936, 0.34, 1.000, 114, 114, PA-IIL LECTIN FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH FUCOSE-DERIVED GLYCOMIMETICS
148, 1ouxA, 0.9930, 0.33, 1.000, 114, 114, LECB (PA-LII) SUGAR-FREE
149, 1ousC, 0.9930, 0.34, 1.000, 114, 114, LECB (PA-LII) CALCIUM-FREE
150, 5mazA, 0.9884, 0.21, 0.867, 113, 113, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-THIOPHENESULFONAMIDE-25-DIMETHYL-N-METHYL-BETA-L- FUCOPYRANOSIDE
151, 5mayC, 0.9883, 0.21, 0.867, 113, 113, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-THIOPHENESULFONAMIDE-N-(BETA-L-FUCOPYRANOSYL METHYL)
152, 5mayA, 0.9879, 0.23, 0.867, 113, 113, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-THIOPHENESULFONAMIDE-N-(BETA-L-FUCOPYRANOSYL METHYL)
153, 4ce8C, 0.9879, 0.23, 1.000, 113, 113, PERDEUTERATED PSEUDOMONAS AERUGINOSA LECTIN II COMPLEX WITH HYDROGENATED L-FUCOSE AND CALCIUM
154, 5a70A, 0.9871, 0.25, 0.867, 113, 113, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE
155, 5mb1C, 0.9796, 0.80, 0.868, 114, 114, STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 246-TRIMETHYLPHENYLSULFONAMIDE-N-METHYL-L- FUCOPYRANOSIDE
156, 1ousA, 0.9792, 0.45, 1.000, 113, 113, LECB (PA-LII) CALCIUM-FREE
157, 1uqxA, 0.9773, 0.48, 0.699, 113, 113, RALSTONIA SOLANACEARUM LECTIN (RS-IIL) IN COMPLEX WITH ALPHA-METHYLMANNOSIDE
158, 2chhA, 0.9767, 0.49, 0.699, 113, 113, RALSTONIA SOLANACEARUM HIGH-AFFINITY MANNOSE-BINDING LECTIN
159, 2boiB, 0.9696, 0.64, 0.611, 113, 113, 1.1A STRUCTURE OF CHROMOBACTERIUM VIOLACEUM LECTIN CV2L IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
160, 2bv4A, 0.9686, 0.65, 0.611, 113, 113, 1.0A STRUCTURE OF CHROMOBACTERIUM VIOLACEUM LECTIN IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE
161, 2bv4B, 0.9683, 0.66, 0.611, 113, 113, 1.0A STRUCTURE OF CHROMOBACTERIUM VIOLACEUM LECTIN IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE
162, 2boiA, 0.9683, 0.66, 0.611, 113, 113, 1.1A STRUCTURE OF CHROMOBACTERIUM VIOLACEUM LECTIN CV2L IN COMPLEX WITH ALPHA-METHYL-FUCOSIDE
163, 1ousD, 0.9516, 0.27, 1.000, 109, 109, LECB (PA-LII) CALCIUM-FREE
164, 2xr4A, 0.9124, 1.34, 0.464, 116, 112, C-TERMINAL DOMAIN OF BC2L-C LECTIN FROM BURKHOLDERIA CENOCEPACIA
165, 2xr4B, 0.9035, 1.67, 0.460, 116, 113, C-TERMINAL DOMAIN OF BC2L-C LECTIN FROM BURKHOLDERIA CENOCEPACIA
166, 2wraA, 0.8968, 1.56, 0.378, 122, 111, BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA COMPLEXED WITH AMAN1(AMAN1-6)-3MAN TRISACCHARIDE
167, 2vnvE, 0.8938, 1.58, 0.378, 128, 111, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
168, 2vnvC, 0.8937, 1.59, 0.378, 127, 111, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
169, 2vnvD, 0.8921, 1.59, 0.378, 128, 111, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
170, 2wr9D, 0.8916, 1.59, 0.378, 124, 111, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE
171, 2vnvB, 0.8915, 1.58, 0.378, 128, 111, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
172, 2wr9C, 0.8896, 1.56, 0.378, 121, 111, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE
173, 4aocB, 0.8881, 1.49, 0.382, 120, 110, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
174, 2wr9A, 0.8874, 1.42, 0.385, 119, 109, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE
175, 2wr9B, 0.8858, 1.62, 0.378, 123, 111, CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE
176, 4aocE, 0.8824, 1.75, 0.378, 121, 111, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
177, 4aocC, 0.8824, 1.64, 0.373, 120, 110, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
178, 2vnvA, 0.8824, 1.67, 0.382, 120, 110, CRYSTAL STRUCTURE OF BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA IN COMPLEX WITH ALPHA-METHYL-MANNOSIDE AT 1.7 ANGSTROM RESOLUTION
179, 4aocD, 0.8765, 1.46, 0.389, 118, 108, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
180, 4aocA, 0.8691, 1.44, 0.383, 117, 107, CRYSTAL STRUCTURE OF BC2L-A LECTIN FROM BURKOLDERIA CENOCEPACIA IN COMPLEX WITH METHYL-HEPTOSIDE
181, 5bzzD, 0.6218, 3.84, 0.065, 314, 108, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
182, 3q13A, 0.6169, 3.53, 0.078, 235, 103, THE STRUCTURE OF THE CA2+-BINDING GLYCOSYLATED F-SPONDIN DOMAIN OF F- SPONDIN A C2-DOMAIN VARIANT FROM EXTRACELLULAR MATRIX
183, 3d34B, 0.6169, 3.54, 0.098, 215, 102, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
184, 5bugB, 0.6167, 3.98, 0.082, 314, 110, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
185, 5bzzC, 0.6154, 4.07, 0.082, 314, 110, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
186, 5bugA, 0.6150, 3.95, 0.083, 314, 109, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
187, 5bzzA, 0.6145, 3.94, 0.083, 314, 109, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
188, 5bzzB, 0.6139, 3.94, 0.083, 314, 109, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
189, 5bzxB, 0.6116, 4.03, 0.082, 314, 110, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
190, 5bugC, 0.6111, 3.99, 0.083, 314, 109, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
191, 5bugD, 0.6106, 3.88, 0.083, 314, 108, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
192, 3d34A, 0.6097, 3.46, 0.121, 211, 99, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
193, 5bzxC, 0.6096, 3.98, 0.083, 314, 109, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
194, 5bzxD, 0.6082, 4.06, 0.091, 314, 110, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
195, 5bzxA, 0.6074, 3.93, 0.083, 314, 108, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
196, 1d5rA, 0.5964, 4.06, 0.093, 307, 108, CRYSTAL STRUCTURE OF THE PTEN TUMOR SUPPRESSOR
197, 4rj9A, 0.5960, 3.44, 0.109, 161, 101, STRUCTURE OF A PLANT SPECIFIC C2 DOMAIN PROTEIN OSGAP1 FROM RICE
198, 1gmiA, 0.5936, 3.63, 0.157, 135, 102, STRUCTURE OF THE C2 DOMAIN FROM NOVEL PROTEIN KINASE C EPSILON
199, 4icwA, 0.5932, 3.56, 0.069, 130, 102, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
200, 2fk9A, 0.5918, 3.37, 0.110, 140, 100, HUMAN PROTEIN KINASE C ETA
201, 3v0hA, 0.5916, 3.92, 0.066, 326, 106, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
202, 6ewpA, 0.5915, 3.65, 0.019, 166, 105, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
203, 5a51A, 0.5900, 3.42, 0.109, 165, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND PHOPHATIDYL SERINE
204, 1djyB, 0.5898, 3.89, 0.067, 561, 104, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-245-TRISPHOSPHATE
205, 1djwB, 0.5891, 3.80, 0.068, 561, 103, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-12-CYCLIC- MONOPHOSPHONATE
206, 6ewpC, 0.5888, 3.54, 0.038, 167, 104, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
207, 2isdB, 0.5888, 3.82, 0.068, 561, 103, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT
208, 1djzB, 0.5888, 3.90, 0.067, 561, 104, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-45-BISPHOSPHATE
209, 1djgB, 0.5886, 3.80, 0.068, 561, 103, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH LANTHANUM
210, 4v29A, 0.5881, 3.38, 0.109, 165, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS
211, 6flkB, 0.5875, 3.59, 0.029, 154, 104, CRYSTAL STRUCTURE OF CEP120 C2C DOMAIN
212, 6ewlA, 0.5875, 3.61, 0.069, 136, 101, DANIO RERIO CEP120 FIRST C2 DOMAIN (C2A) 
213, 5a4xA, 0.5870, 3.41, 0.109, 158, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND ZN
214, 3v0gB, 0.5869, 3.99, 0.057, 334, 106, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
215, 4qamB, 0.5868, 3.71, 0.097, 175, 103, CRYSTAL STRUCTURE OF THE RPGR RCC1-LIKE DOMAIN IN COMPLEX WITH THE RPGR-INTERACTING DOMAIN OF RPGRIP1
216, 4npjA, 0.5866, 3.48, 0.069, 292, 101, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
217, 4ihbE, 0.5866, 3.40, 0.110, 126, 100, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
218, 4ihbA, 0.5866, 3.28, 0.111, 126, 99, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
219, 4p42A, 0.5858, 3.47, 0.059, 455, 101, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
220, 3v0gA, 0.5858, 3.96, 0.066, 326, 106, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
221, 1djhA, 0.5857, 3.84, 0.087, 513, 104, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH BARIUM
222, 1djwA, 0.5855, 3.83, 0.087, 513, 104, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-12-CYCLIC- MONOPHOSPHONATE
223, 5a51B, 0.5854, 3.44, 0.109, 165, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND PHOPHATIDYL SERINE
224, 3v0hB, 0.5851, 3.96, 0.066, 327, 106, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
225, 1djiA, 0.5851, 3.92, 0.086, 513, 105, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM
226, 1djiB, 0.5850, 3.98, 0.086, 559, 105, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM
227, 1djhB, 0.5848, 3.99, 0.086, 559, 105, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH BARIUM
228, 5a50A, 0.5847, 3.41, 0.109, 165, 101, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS ZN AND PHOPHO CHOLINE
229, 1djzA, 0.5843, 3.88, 0.086, 513, 105, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-45-BISPHOSPHATE
230, 3v0gC, 0.5832, 3.94, 0.057, 324, 105, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
231, 1djxB, 0.5832, 3.86, 0.068, 561, 103, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-145-TRISPHOSPHATE
232, 6flkA, 0.5830, 3.52, 0.029, 154, 103, CRYSTAL STRUCTURE OF CEP120 C2C DOMAIN
233, 2vmhA, 0.5825, 2.76, 0.119, 147, 84, THE STRUCTURE OF CBM51 FROM CLOSTRIDIUM PERFRINGENS GH95
234, 2vmgA, 0.5822, 2.79, 0.119, 145, 84, THE STRUCTURE OF CBM51 FROM CLOSTRIDIUM PERFRINGENS GH95 IN COMPLEX WITH METHYL-GALACTOSE
235, 4v29B, 0.5820, 3.34, 0.110, 165, 100, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS
236, 6fljA, 0.5819, 3.63, 0.079, 127, 101, CRYSTAL STRUCTURE OF CEP120 C2A_K76A MUTANT
237, 4ihbD, 0.5818, 3.41, 0.110, 128, 100, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
238, 3l4cA, 0.5818, 3.45, 0.072, 178, 97, STRUCTURAL BASIS OF MEMBRANE-TARGETING BY DOCK180
239, 4npkA, 0.5817, 3.33, 0.070, 269, 100, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS CALCIUM BOUND
240, 4icxC, 0.5816, 3.63, 0.069, 130, 101, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
241, 4ihbB, 0.5815, 3.39, 0.110, 126, 100, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
242, 3w56A, 0.5815, 3.25, 0.053, 108, 95, STRUCTURE OF A C2 DOMAIN
243, 3aweA, 0.5815, 3.94, 0.067, 305, 104, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
244, 5a4xB, 0.5814, 3.37, 0.110, 163, 100, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND ZN
245, 1qasA, 0.5813, 4.01, 0.086, 505, 105, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1
246, 1wfjA, 0.5812, 3.52, 0.090, 136, 100, C2 DOMAIN-CONTAINING PROTEIN FROM PUTATIVE ELICITOR- RESPONSIVE GENE
247, 1qatB, 0.5812, 3.98, 0.086, 507, 105, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA COMPLEX WITH SAMARIUM (III) CHLORIDE
248, 4ihbF, 0.5808, 3.38, 0.110, 126, 100, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
249, 3v0gD, 0.5806, 4.05, 0.065, 325, 107, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
250, 5a50B, 0.5805, 3.35, 0.110, 165, 100, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS ZN AND PHOPHO CHOLINE
251, 4ihbC, 0.5804, 3.47, 0.110, 127, 100, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
252, 3v0jB, 0.5800, 3.85, 0.057, 320, 105, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) DELETION OF 401-405
253, 3jzyA, 0.5799, 3.47, 0.071, 124, 99, CRYSTAL STRUCTURE OF HUMAN INTERSECTIN 2 C2 DOMAIN
254, 1qatA, 0.5799, 3.90, 0.086, 509, 105, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA COMPLEX WITH SAMARIUM (III) CHLORIDE
255, 5a52A, 0.5797, 3.45, 0.080, 154, 100, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR1 IN COMPLEX WITH ONE CALCIUM ION
256, 4icxA, 0.5797, 3.65, 0.069, 132, 101, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
257, 6ewpB, 0.5795, 3.63, 0.058, 171, 104, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
258, 3qr1A, 0.5795, 3.63, 0.090, 781, 100, CRYSTAL STRUCTURE OF L. PEALEI PLC21
259, 2cjtB, 0.5794, 3.62, 0.081, 121, 99, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
260, 1cjyA, 0.5793, 3.43, 0.051, 633, 98, HUMAN CYTOSOLIC PHOSPHOLIPASE A2
261, 4icxB, 0.5792, 3.57, 0.079, 129, 101, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
262, 2vmiA, 0.5791, 2.78, 0.119, 144, 84, THE STRUCTURE OF SELENO-METHIONINE LABELLED CBM51 FROM CLOSTRIDIUM PERFRINGENS GH95
263, 2isdA, 0.5790, 3.64, 0.078, 513, 103, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT
264, 4qj3B, 0.5788, 3.59, 0.100, 756, 100, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-559 IN COMPLEX WITH GALPHAQ
265, 3awgB, 0.5788, 3.98, 0.067, 306, 105, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
266, 2cjtA, 0.5788, 3.63, 0.081, 121, 99, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
267, 5ue8A, 0.5783, 3.76, 0.109, 847, 101, THE CRYSTAL STRUCTURE OF MUNC13-1 C1C2BMUN DOMAIN
268, 4npjB, 0.5778, 3.52, 0.059, 282, 101, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
269, 4xoiB, 0.5776, 3.72, 0.050, 210, 101, STRUCTURE OF HSANILLIN BOUND WITH RHOA(Q63L) AT 2.1 ANGSTROMS RESOLUTION
270, 2yglA, 0.5775, 2.87, 0.058, 351, 86, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71
271, 1djxA, 0.5767, 3.65, 0.078, 513, 103, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-145-TRISPHOSPHATE
272, 2yrbA, 0.5766, 3.73, 0.067, 156, 104, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN FROM HUMAN KIAA1005 PROTEIN
273, 2cjsA, 0.5766, 3.74, 0.081, 163, 99, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
274, 4y1sA, 0.5765, 3.19, 0.084, 122, 95, STRUCTURAL BASIS FOR CA2+-MEDIATED INTERACTION OF THE PERFORIN C2 DOMAIN WITH LIPID MEMBRANES
275, 1djgA, 0.5760, 3.66, 0.078, 513, 103, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH LANTHANUM
276, 3l4cB, 0.5758, 3.87, 0.059, 179, 101, STRUCTURAL BASIS OF MEMBRANE-TARGETING BY DOCK180
277, 1djyA, 0.5757, 3.65, 0.078, 513, 103, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-245-TRISPHOSPHATE
278, 1cjyB, 0.5755, 3.49, 0.051, 614, 98, HUMAN CYTOSOLIC PHOSPHOLIPASE A2
279, 1rlwA, 0.5751, 3.50, 0.061, 126, 99, CALCIUM-PHOSPHOLIPID BINDING DOMAIN FROM CYTOSOLIC PHOSPHOLIPASE A2
280, 4gnkD, 0.5750, 3.52, 0.082, 766, 98, CRYSTAL STRUCTURE OF GALPHAQ IN COMPLEX WITH FULL-LENGTH HUMAN PLCBETA3
281, 3w57A, 0.5749, 3.16, 0.053, 111, 94, STRUCTURE OF A C2 DOMAIN
282, 2cjsB, 0.5742, 3.59, 0.092, 156, 98, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
283, 3aweB, 0.5736, 3.89, 0.067, 307, 104, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
284, 3kwtA, 0.5735, 3.32, 0.104, 116, 96, MUNC13-1 C2B-DOMAIN CALCIUM-FREE
285, 4y1tA, 0.5734, 3.19, 0.084, 126, 95, STRUCTURAL BASIS FOR CA2+-MEDIATED INTERACTION OF THE PERFORIN C2 DOMAIN WITH LIPID MEMBRANES
286, 5ug6A, 0.5730, 3.20, 0.084, 123, 95, PERFORIN C2 DOMAIN - T431D
287, 2nq3A, 0.5730, 3.81, 0.087, 131, 104, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN ITCHY HOMOLOG E3 UBIQUITIN PROTEIN LIGASE
288, 2ep6A, 0.5730, 3.41, 0.063, 133, 95, SOLUTION STRUCTURE OF THE SECOND C2 DOMAIN FROM HUMAN MCTP2 PROTEIN
289, 1bciA, 0.5730, 3.45, 0.061, 123, 98, C2 DOMAIN OF CYTOSOLIC PHOSPHOLIPASE A2 NMR MINIMIZED AVERAGE STRUCTURE
290, 3qr1D, 0.5729, 3.92, 0.078, 775, 103, CRYSTAL STRUCTURE OF L. PEALEI PLC21
291, 5ug7A, 0.5728, 3.21, 0.084, 126, 95, CALCIUM BOUND PERFORIN C2 DOMAIN - T431D
292, 3nsjA, 0.5725, 3.19, 0.095, 530, 95, THE X-RAY CRYSTAL STRUCTURE OF LYMPHOCYTE PERFORIN
293, 3qr0A, 0.5723, 3.96, 0.067, 781, 104, CRYSTAL STRUCTURE OF S. OFFICINALIS PLC21
294, 2zkmX, 0.5722, 3.62, 0.080, 708, 100, CRYSTAL STRUCTURE OF PHOSPHOLIPASE C BETA 2
295, 1qasB, 0.5721, 3.80, 0.067, 504, 104, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1
296, 2cjtC, 0.5708, 3.61, 0.083, 127, 96, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
297, 2ygmA, 0.5702, 2.95, 0.069, 351, 87, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN
298, 3w57B, 0.5701, 3.18, 0.053, 111, 94, STRUCTURE OF A C2 DOMAIN
299, 3awfA, 0.5696, 4.03, 0.067, 304, 104, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
300, 2jqzA, 0.5694, 3.64, 0.140, 131, 100, SOLUTION STRUCTURE OF THE C2 DOMAIN OF HUMAN SMURF2
301, 3m7fB, 0.5693, 3.76, 0.101, 135, 99, CRYSTAL STRUCTURE OF THE NEDD4 C2/GRB10 SH2 COMPLEX
302, 3pycA, 0.5692, 3.71, 0.121, 132, 99, CRYSTAL STRUCTURE OF HUMAN SMURF1 C2 DOMAIN
303, 3kwuA, 0.5686, 3.56, 0.101, 135, 99, MUNC13-1 C2B-DOMAIN CALCIUM BOUND
304, 4iqhA, 0.5680, 3.67, 0.110, 128, 100, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
305, 4iqhC, 0.5674, 3.55, 0.120, 128, 100, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
306, 4gnkB, 0.5672, 3.54, 0.080, 769, 100, CRYSTAL STRUCTURE OF GALPHAQ IN COMPLEX WITH FULL-LENGTH HUMAN PLCBETA3
307, 2vnoB, 0.5669, 2.97, 0.093, 173, 86, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP B-TRISACCHARIDE LIGAND.
308, 2vngB, 0.5667, 2.96, 0.093, 173, 86, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP A-TRISACCHARIDE LIGAND.
309, 3b7yA, 0.5665, 3.81, 0.101, 144, 99, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE E3 UBIQUITIN- PROTEIN LIGASE NEDD4
310, 4qj4B, 0.5664, 4.12, 0.049, 749, 103, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-569 BOUND TO IP3 AND IN COMPLEX WITH GALPHAQ
311, 2zxqA, 0.5663, 2.65, 0.167, 1178, 84, CRYSTAL STRUCTURE OF ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE FROM BIFIDOBACTERIUM LONGUM (ENGBF)
312, 5ue8B, 0.5662, 3.43, 0.113, 838, 97, THE CRYSTAL STRUCTURE OF MUNC13-1 C1C2BMUN DOMAIN
313, 2cjtD, 0.5660, 3.69, 0.083, 127, 96, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
314, 2vnrA, 0.5658, 2.94, 0.093, 172, 86, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS.
315, 2nsqA, 0.5654, 3.96, 0.061, 140, 99, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE HUMAN E3 UBIQUITIN-PROTEIN LIGASE NEDD4-LIKE PROTEIN
316, 2vnoA, 0.5643, 2.98, 0.093, 171, 86, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP B-TRISACCHARIDE LIGAND.
317, 2fjuB, 0.5643, 3.56, 0.121, 696, 99, ACTIVATED RAC1 BOUND TO ITS EFFECTOR PHOSPHOLIPASE C BETA 2
318, 2vngA, 0.5641, 2.98, 0.093, 171, 86, FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP A-TRISACCHARIDE LIGAND.
319, 2dmhA, 0.5628, 3.67, 0.101, 140, 99, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF HUMAN MYOFERLIN
320, 3ohmB, 0.5625, 3.55, 0.120, 759, 100, CRYSTAL STRUCTURE OF ACTIVATED G ALPHA Q BOUND TO ITS EFFECTOR PHOSPHOLIPASE C BETA 3
321, 4xh3A, 0.5622, 3.77, 0.059, 214, 101, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
322, 6ewiB, 0.5620, 3.70, 0.119, 182, 101, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) A200P + G307S MUTANT 
323, 5iz5A, 0.5618, 3.71, 0.071, 757, 99, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
324, 3l9bA, 0.5617, 3.57, 0.071, 126, 99, CRYSTAL STRUCTURE OF RAT OTOFERLIN C2A
325, 3b7yB, 0.5606, 3.69, 0.101, 146, 99, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE E3 UBIQUITIN- PROTEIN LIGASE NEDD4
326, 4itcA, 0.5593, 2.94, 0.059, 169, 85, CRYSTAL STRUCTURE ANALYSIS OF THE K1 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
327, 4p42B, 0.5592, 3.68, 0.040, 431, 99, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
328, 3m1hD, 0.5592, 2.96, 0.094, 176, 85, CRYSTAL STRUCTURE ANALYSIS OF THE K3 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
329, 6ewhA, 0.5589, 3.84, 0.117, 181, 103, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) G307S MUTANT 
330, 3m1hB, 0.5589, 2.83, 0.083, 175, 84, CRYSTAL STRUCTURE ANALYSIS OF THE K3 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
331, 6ewgA, 0.5587, 3.78, 0.127, 181, 102, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) 
332, 4xoiD, 0.5587, 3.84, 0.069, 208, 102, STRUCTURE OF HSANILLIN BOUND WITH RHOA(Q63L) AT 2.1 ANGSTROMS RESOLUTION
333, 4qj5B, 0.5586, 3.59, 0.110, 747, 100, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-581 BOUND TO IP3 AND IN COMPLEX WITH GALPHAQ
334, 3n0aA, 0.5565, 4.28, 0.064, 335, 110, CRYSTAL STRUCTURE OF AUXILIN (40-400)
335, 6ewiA, 0.5563, 4.12, 0.066, 174, 106, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) A200P + G307S MUTANT 
336, 5izrA, 0.5557, 3.59, 0.072, 674, 97, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
337, 5izrB, 0.5556, 3.59, 0.072, 675, 97, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
338, 5ixcB, 0.5555, 3.55, 0.074, 680, 95, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE
339, 4gwnA, 0.5552, 2.95, 0.118, 533, 85, CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA
340, 3m1hC, 0.5552, 3.09, 0.082, 170, 85, CRYSTAL STRUCTURE ANALYSIS OF THE K3 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
341, 3m1hA, 0.5552, 3.02, 0.083, 174, 84, CRYSTAL STRUCTURE ANALYSIS OF THE K3 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP) FROM PORPHYROMONAS GINGIVALIS W83
342, 5izrC, 0.5550, 3.53, 0.074, 659, 95, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
343, 5izrD, 0.5547, 3.56, 0.052, 664, 96, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
344, 5a55A, 0.5546, 3.01, 0.131, 1100, 84, THE NATIVE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4
345, 4gwmA, 0.5541, 3.11, 0.093, 561, 86, CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA
346, 5ixcA, 0.5538, 3.75, 0.062, 684, 97, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE
347, 4iqhB, 0.5538, 3.54, 0.101, 127, 99, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
348, 5a56A, 0.5530, 3.15, 0.129, 1106, 85, THE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH 1-O-METHYL-T-ANTIGEN
349, 3v0dB, 0.5529, 4.00, 0.086, 324, 105, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S)
350, 5a58A, 0.5528, 3.15, 0.129, 1106, 85, THE STRUCTURE OF GH101 D764N MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH SERINYL T-ANTIGEN
351, 4gwmB, 0.5528, 3.07, 0.105, 554, 86, CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA
352, 5a5aA, 0.5526, 3.15, 0.129, 1106, 85, THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH PNP-T-ANTIGEN
353, 3v0fA, 0.5523, 3.99, 0.086, 331, 105, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM II
354, 3v0dA, 0.5521, 4.20, 0.084, 324, 107, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S)
355, 5a57A, 0.5517, 3.15, 0.129, 1107, 85, THE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH PUGT
356, 3v0jA, 0.5516, 4.01, 0.086, 319, 105, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) DELETION OF 401-405
357, 5a59A, 0.5512, 3.14, 0.129, 1106, 85, THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH T-ANTIGEN
358, 3v0eA, 0.5510, 4.18, 0.084, 320, 107, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 256-576(C363S)
359, 3v0fB, 0.5501, 3.98, 0.096, 323, 104, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM II
360, 2ygmB, 0.5499, 3.30, 0.092, 352, 87, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN
361, 5dfzA, 0.5495, 3.52, 0.062, 343, 97, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
362, 3awgC, 0.5486, 4.19, 0.095, 308, 105, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
363, 5iz5B, 0.5483, 3.80, 0.011, 746, 94, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
364, 3v0iA, 0.5482, 3.95, 0.087, 293, 104, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 256-576 E411F
365, 3aweC, 0.5469, 4.00, 0.087, 308, 104, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
366, 3ecqA, 0.5466, 3.01, 0.145, 1313, 83, ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE: SEMET STRUCTURE
367, 2qzqA, 0.5465, 3.67, 0.061, 149, 98, CRYSTAL STRUCTURE OF C-TERMINAL OF AIDA
368, 2c9aA, 0.5464, 2.85, 0.143, 256, 84, CRYSTAL STRUCTURE OF THE MAM-IG MODULE OF RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU
369, 3km5A, 0.5463, 2.94, 0.107, 179, 84, CRYSTAL STRUCTURE ANALYSIS OF THE K2 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP)
370, 2qz5B, 0.5462, 3.69, 0.030, 154, 99, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF AIDA
371, 2wxhA, 0.5459, 4.02, 0.068, 822, 103, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW14.
372, 2wxgA, 0.5456, 3.89, 0.069, 835, 102, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW13.
373, 3awfC, 0.5449, 4.22, 0.085, 310, 106, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
374, 1pmjX, 0.5449, 3.15, 0.080, 185, 87, CRYSTAL STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS CBM27-1
375, 3awfB, 0.5445, 4.04, 0.087, 308, 104, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
376, 5l72A, 0.5443, 3.89, 0.069, 858, 102, PI3 KINASE DELTA IN COMPLEX WITH N-[6-(5-METHANESULFONAMIDO-6- METHOXYPYRIDIN-3-YL)-13-DIHYDRO-2-BENZOFURAN-4-YL]-2-(MORPHOLIN-4- YL)ACETAMIDE
377, 2wxqA, 0.5442, 3.78, 0.079, 822, 101, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH AS15.
378, 6al6A, 0.5441, 3.08, 0.082, 194, 85, CRYSTAL STRUCTURE HPIC1 IN P42 SPACE GROUP
379, 2yglB, 0.5439, 3.10, 0.094, 350, 85, THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98 THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71
380, 3awgA, 0.5437, 4.03, 0.078, 306, 103, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
381, 2wxiA, 0.5437, 3.87, 0.079, 815, 101, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW30.
382, 5t8iA, 0.5435, 3.87, 0.059, 808, 101, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-9901
383, 6al6B, 0.5433, 3.09, 0.082, 197, 85, CRYSTAL STRUCTURE HPIC1 IN P42 SPACE GROUP
384, 2wxmA, 0.5433, 3.92, 0.069, 822, 102, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH DL06.
385, 2wxkA, 0.5432, 3.71, 0.070, 835, 100, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH INK666.
386, 5t7fB, 0.5426, 3.85, 0.059, 816, 101, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-643624
387, 5t2lA, 0.5426, 3.82, 0.059, 830, 101, MPI3KD IN COMPLEX WITH 7L
388, 6ftnA, 0.5423, 3.84, 0.059, 827, 101, MPI3KD IN COMPLEX WITH AZ2 
389, 5azxA, 0.5423, 2.79, 0.038, 100, 79, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
390, 5m6uA, 0.5420, 3.77, 0.091, 916, 99, HUMAN PI3KDELTA IN COMPLEX WITH LASW1579
391, 4v0iB, 0.5420, 3.77, 0.050, 792, 100, WATER NETWORK DETERMINES SELECTIVITY FOR A SERIES OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS OVER PI3K-DELTA
392, 6al8D, 0.5419, 3.10, 0.094, 197, 85, CRYSTAL STRUCTURE HPIC1 Y101F/F138S
393, 4ajwB, 0.5417, 3.85, 0.050, 792, 100, DISCOVERY AND OPTIMIZATION OF NEW BENZIMIDAZOLE- AND BENZOXAZOLE- PYRIMIDONE SELECTIVE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
394, 2wxlA, 0.5415, 3.96, 0.069, 823, 102, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH ZSTK474.
395, 6al7B, 0.5414, 3.10, 0.094, 200, 85, CRYSTAL STRUCTURE HPIC1 F138S
396, 5okmB, 0.5414, 4.21, 0.057, 442, 106, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
397, 4xe0A, 0.5414, 4.01, 0.078, 815, 103, IDELALISIB BOUND TO THE P110 SUBUNIT OF PI3K DELTA
398, 5wppA, 0.5413, 3.10, 0.082, 199, 85, CRYSTAL STRUCTURE HPIC1 W73M/K132M
399, 6al8B, 0.5412, 3.10, 0.094, 200, 85, CRYSTAL STRUCTURE HPIC1 Y101F/F138S
400, 6al8A, 0.5411, 3.12, 0.094, 197, 85, CRYSTAL STRUCTURE HPIC1 Y101F/F138S
401, 5azwA, 0.5409, 2.74, 0.114, 94, 79, CRYSTAL STRUCTURE OF P24BETA1 GOLD DOMAIN
402, 5vlrA, 0.5408, 3.76, 0.040, 926, 100, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A TRIFLUORO-ETHYL- PYRAZOL-PYROLOTRIAZINE INHIBITOR
403, 2wxpA, 0.5408, 3.90, 0.059, 822, 102, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH GDC-0941.
404, 5wppB, 0.5406, 3.11, 0.082, 198, 85, CRYSTAL STRUCTURE HPIC1 W73M/K132M
405, 5wpuA, 0.5405, 3.11, 0.082, 199, 85, CRYSTAL STRUCTURE HPIC1 Y101S
406, 5t7fA, 0.5405, 3.87, 0.059, 819, 101, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-643624
407, 5oknD, 0.5405, 4.03, 0.068, 433, 103, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
408, 3ibeA, 0.5405, 3.75, 0.102, 850, 98, CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR BOUND TO PI3 KINASE GAMMA
409, 5wpsA, 0.5402, 2.94, 0.071, 199, 84, CRYSTAL STRUCTURE HPIC1 Y101F
410, 6al7D, 0.5399, 3.11, 0.094, 198, 85, CRYSTAL STRUCTURE HPIC1 F138S
411, 3km5B, 0.5399, 3.00, 0.107, 173, 84, CRYSTAL STRUCTURE ANALYSIS OF THE K2 CLEAVED ADHESIN DOMAIN OF LYS- GINGIPAIN (KGP)
412, 5azwB, 0.5398, 2.56, 0.117, 93, 77, CRYSTAL STRUCTURE OF P24BETA1 GOLD DOMAIN
413, 5ae8A, 0.5398, 4.00, 0.058, 856, 103, CRYSTAL STRUCTURE OF MOUSE PI3 KINASE DELTA IN COMPLEX WITH GSK2269557
414, 6al7A, 0.5397, 3.19, 0.105, 198, 86, CRYSTAL STRUCTURE HPIC1 F138S
415, 5wprA, 0.5396, 3.11, 0.082, 200, 85, CRYSTAL STRUCTURE HPIC1 IN C2 SPACE GROUP
416, 3ps6A, 0.5393, 3.96, 0.020, 841, 100, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
417, 3przA, 0.5391, 4.04, 0.020, 844, 101, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
418, 5gu5A, 0.5388, 2.69, 0.052, 108, 77, CRYSTAL STRUCTURE OF P24GAMMA2 GOLD DOMAIN DETERMINED BY SULFUR-SAD
419, 4xohB, 0.5387, 3.93, 0.069, 268, 102, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
420, 2wxfA, 0.5386, 3.88, 0.079, 822, 101, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH PIK-39.
421, 2qz5A, 0.5382, 3.91, 0.020, 152, 100, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF AIDA
422, 2wxjA, 0.5380, 3.87, 0.059, 822, 101, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH INK654.
423, 6ez6A, 0.5379, 3.77, 0.070, 863, 100, PI3 KINASE DELTA IN COMPLEX WITH METHYL 5-(4-(5-((4- ISOPROPYLPIPERAZIN-1-YL)METHYL)OXAZOL-2-YL)-1H-INDAZOL-6-YL)-2- METHOXYNICOTINATE
424, 6dgtA, 0.5376, 3.91, 0.059, 777, 101, SELECTIVE PI3K BETA INHIBITOR BOUND TO PI3K DELTA 
425, 6eyzA, 0.5375, 3.87, 0.080, 862, 100, PI3 KINASE DELTA IN COMPLEX WITH 4-FLUOROPHENYL 5-(4-(5-((4- ISOPROPYLPIPERAZIN-1-YL)METHYL)OXAZOL-2-YL)-1H-INDAZOL-6-YL)-2- METHOXYNICOTINATE
426, 3qarA, 0.5372, 3.83, 0.092, 834, 98, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 32
427, 5okmC, 0.5371, 4.22, 0.075, 431, 106, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
428, 5ae9A, 0.5371, 3.88, 0.059, 858, 101, CRYSTAL STRUCTURE OF MOUSE PI3 KINASE DELTA IN COMPLEX WITH GSK2292767
429, 1he8A, 0.5371, 3.94, 0.101, 749, 99, RAS G12V - PI 3-KINASE GAMMA COMPLEX
430, 2xonL, 0.5368, 3.27, 0.046, 146, 87, STRUCTURE OF TMCBM61 IN COMPLEX WITH BETA-14-GALACTOTRIOSE AT 1.4 A RESOLUTION
431, 5t27A, 0.5367, 3.93, 0.069, 819, 101, MPI3KD IN COMPLEX WITH 5D
432, 2wxrA, 0.5364, 3.85, 0.069, 822, 101, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA.
433, 3lj3A, 0.5360, 4.04, 0.030, 829, 101, PI3-KINASE-GAMMA WITH A PYRROLOPYRIDINE-BENZOFURAN INHIBITOR
434, 3ml9A, 0.5358, 3.95, 0.030, 847, 100, DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN
435, 5okmA, 0.5355, 4.05, 0.078, 435, 103, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
436, 5g55A, 0.5353, 4.11, 0.039, 847, 102, 3-QUINOLINE CARBOXAMIDES INHIBITORS OF PI3K
437, 2wxoA, 0.5350, 3.97, 0.049, 822, 102, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH AS5.
438, 4xohA, 0.5348, 3.98, 0.099, 266, 101, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
439, 4fjzA, 0.5345, 3.78, 0.092, 822, 98, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH PYRROLO-PYRIDINE INHIBITOR 63
440, 5mvxA, 0.5342, 3.72, 0.041, 299, 98, HUMAN DLL4 C2-EGF3
441, 2x38A, 0.5338, 4.07, 0.039, 822, 102, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH IC87114.
442, 4urkA, 0.5337, 3.99, 0.030, 837, 100, PI3KG IN COMPLEX WITH AZD6482
443, 4fadA, 0.5337, 3.98, 0.030, 839, 100, DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR
444, 5t28A, 0.5334, 4.01, 0.049, 822, 102, MPI3KD IN COMPLEX WITH 5K
445, 5sxjA, 0.5334, 4.10, 0.010, 1039, 101, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 29
446, 5okoA, 0.5331, 4.22, 0.066, 427, 106, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
447, 5ngbA, 0.5330, 4.03, 0.039, 816, 103, X-RAY DIFFRACTION CRYSTAL STRUCTURE OF THE MURINE PI3K P110DELTA IN COMPLEX WITH A PAN INHIBITOR
448, 4kz0A, 0.5328, 4.13, 0.030, 833, 101, STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS
449, 1pmhX, 0.5325, 3.10, 0.058, 181, 86, CRYSTAL STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS CBM27-1 IN COMPLEX WITH MANNOHEXAOSE
450, 5i4uA, 0.5323, 4.07, 0.029, 815, 103, THE CRYSTAL STRUCTURE OF PI3KDELTA WITH COMPOUND 34
451, 3preA, 0.5321, 3.80, 0.031, 839, 98, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
452, 4wwpA, 0.5319, 3.78, 0.092, 820, 98, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH PYRIDINYLQUINOLINE INHIBITOR N-{(1S)-1-[8-CHLORO-2-(2-METHYLPYRIDIN- 3-YL)QUINOLIN-3-YL]ETHYL}-9H-PURIN-6-AMINE
453, 5azxC, 0.5318, 2.75, 0.064, 100, 78, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
454, 3qk0A, 0.5314, 3.86, 0.092, 820, 98, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH BENZOTHIAZOLE 82
455, 3csfA, 0.5314, 3.99, 0.040, 839, 99, CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR DW2
456, 2wxnA, 0.5313, 3.88, 0.040, 822, 101, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH DL07.
457, 3p2bA, 0.5312, 4.00, 0.040, 808, 100, CRYSTAL STRUCTURE OF PI3K GAMMA WITH 3-(2-MORPHOLINO-6-(PYRIDIN-3- YLAMINO)PYRIMIDIN-4-YL)PHENOL
458, 3sd5A, 0.5311, 4.00, 0.040, 817, 100, CRYSTAL STRUCTURE OF PI3K GAMMA WITH 5-(24-DIMORPHOLINOPYRIMIDIN-6- YL)-4-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE
459, 4fulA, 0.5310, 3.88, 0.070, 832, 100, PI3 KINASE GAMMA BOUND TO A PYRMIDINE INHIBITOR
460, 3apfA, 0.5310, 3.89, 0.061, 840, 99, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5039699
461, 1ux7A, 0.5310, 2.98, 0.146, 119, 82, CARBOHYDRATE-BINDING MODULE CBM36 IN COMPLEX WITH CALCIUM AND XYLOTRIOSE
462, 5mwfD, 0.5309, 3.80, 0.122, 266, 98, HUMAN JAGGED2 C2-EGF2
463, 1w0nA, 0.5309, 2.91, 0.146, 120, 82, STRUCTURE OF UNCOMPLEXED CARBOHYDRATE BINDING DOMAIN CBM36
464, 4xohC, 0.5308, 4.03, 0.078, 268, 102, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
465, 4wwnA, 0.5307, 4.04, 0.059, 831, 101, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH (S)-N-(1-(7- FLUORO-2-(PYRIDIN-2-YL)QUINOLIN-3-YL)ETHYL)-9H-PURIN-6-AMINE AMG319 INHIBITOR
466, 2a4zA, 0.5307, 4.07, 0.030, 812, 100, CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS604850
467, 5okoB, 0.5306, 4.22, 0.048, 426, 104, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
468, 5okpA, 0.5305, 4.09, 0.069, 421, 102, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
469, 4jqrA, 0.5298, 3.46, 0.115, 218, 87, CRYSTAL STRUCTURE OF A DUF4465 FAMILY PROTEIN (BACCAC_02373) FROM BACTEROIDES CACCAE ATCC 43185 AT 2.05 A RESOLUTION
470, 2dduA, 0.5298, 2.87, 0.095, 301, 84, CRYSTAL STRUCTURE OF THE THIRD REPEAT DOMAIN OF REELIN
471, 5sxaA, 0.5297, 3.99, 0.030, 1049, 101, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 10
472, 5edsA, 0.5295, 3.77, 0.093, 823, 97, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH BENZIMIDAZOLE INHIBITOR 5
473, 4cbzB, 0.5294, 3.86, 0.052, 252, 97, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
474, 5t23A, 0.5288, 4.11, 0.030, 804, 101, PI3KG IN COMPLEX WITH 5D
475, 2chxA, 0.5287, 4.11, 0.040, 842, 101, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90
476, 4anuA, 0.5286, 4.10, 0.040, 833, 101, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
477, 4anwA, 0.5285, 4.09, 0.040, 833, 101, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
478, 2a5uA, 0.5284, 3.99, 0.040, 839, 99, CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS605240
479, 5okmH, 0.5281, 4.22, 0.057, 427, 105, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
480, 4fjyA, 0.5281, 3.89, 0.030, 839, 99, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH QUINOLINE-INDOLINE INHIBITOR 24F
481, 3eneA, 0.5280, 4.37, 0.041, 843, 97, COMPLEX OF PI3K GAMMA WITH AN INHIBITOR
482, 2xonA, 0.5280, 3.29, 0.047, 145, 86, STRUCTURE OF TMCBM61 IN COMPLEX WITH BETA-14-GALACTOTRIOSE AT 1.4 A RESOLUTION
483, 5ubtA, 0.5278, 4.09, 0.049, 911, 102, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
484, 5ncyA, 0.5278, 3.91, 0.030, 827, 100, MPI3KD IN COMPLEX WITH INH1
485, 5dxtA, 0.5276, 3.93, 0.040, 879, 99, P110ALPHA WITH GDC-0326
486, 4dk5A, 0.5276, 3.87, 0.051, 834, 99, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL- TRIAZINE INHIBITOR
487, 5mwfE, 0.5275, 3.68, 0.031, 260, 96, HUMAN JAGGED2 C2-EGF2
488, 4cc1A, 0.5275, 3.76, 0.062, 306, 97, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
489, 3r7qA, 0.5275, 4.18, 0.030, 837, 101, STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3- KINASE
490, 4cbzA, 0.5274, 3.88, 0.052, 291, 97, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
491, 6gq7A, 0.5273, 4.03, 0.030, 802, 100, PI3KG IN COMPLEX WITH INH 
492, 1e8xA, 0.5273, 4.25, 0.042, 841, 96, STRUCTURAL INSIGHTS INTO PHOSHOINOSITIDE 3-KINASE ENZYMATIC MECHANISM AND SIGNALLING
493, 3apdA, 0.5271, 3.88, 0.020, 839, 98, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5108134
494, 2xomA, 0.5268, 3.17, 0.035, 145, 85, ATOMIC RESOLUTION STRUCTURE OF TMCBM61 IN COMPLEX WITH BETA- 14-GALACTOTRIOSE
495, 4ovuA, 0.5267, 3.85, 0.040, 1044, 99, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH NISH2 OF P85ALPHA
496, 1e8wA, 0.5267, 4.09, 0.040, 851, 101, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
497, 5kaeA, 0.5266, 4.27, 0.049, 840, 102, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH QUINOLINE- CONTAINING INHIBITOR 5G
498, 3tjpA, 0.5266, 4.01, 0.030, 840, 99, CRYSTAL STRUCTURE OF PI3K GAMMA WITH N6-(34-DIMETHOXYPHENYL)-2- MORPHOLINO-[45 -BIPYRIMIDINE]-2 6-DIAMINE
499, 5dxhA, 0.5264, 4.17, 0.029, 989, 102, P110ALPHA/P85ALPHA WITH COMPOUND 5
500, 5t2bA, 0.5263, 3.95, 0.040, 820, 99, MPI3KD IN COMPLEX WITH 5E
501, 5mwfC, 0.5261, 3.67, 0.031, 262, 96, HUMAN JAGGED2 C2-EGF2
502, 3s2aA, 0.5261, 3.97, 0.051, 834, 98, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH A QUINOLINE INHIBITOR
503, 3hizA, 0.5261, 3.97, 0.030, 1024, 101, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA
504, 4l2yA, 0.5260, 4.22, 0.039, 991, 102, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND COMPOUND 9D
505, 3tl5A, 0.5260, 3.98, 0.040, 845, 99, DISCOVERY OF GDC-0980: A POTENT SELECTIVE AND ORALLY AVAILABLE CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K)/MAMMALIAN TARGET OF RAPAMYCIN (MTOR) KINASE INHIBITOR FOR THE TREATMENT OF CANCER
506, 5okmG, 0.5258, 4.23, 0.085, 431, 106, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
507, 4a55A, 0.5258, 4.15, 0.029, 1001, 102, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH ISH2 OF P85ALPHA AND THE INHIBITOR PIK-108
508, 3mjwA, 0.5258, 3.99, 0.071, 819, 99, PI3 KINASE GAMMA WITH A BENZOFURANONE INHIBITOR
509, 4anxA, 0.5257, 3.98, 0.040, 833, 99, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
510, 2enqA, 0.5257, 4.10, 0.030, 158, 101, SOLUTION STRUCTURE OF THE C2 DOMAIN FROM HUMAN PI3-KINASE P110 SUBUNIT ALPHA
511, 4fa6A, 0.5256, 4.02, 0.051, 842, 99, DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR
512, 6ankB, 0.5255, 3.54, 0.090, 263, 89, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
513, 5ubrA, 0.5255, 3.97, 0.040, 887, 100, CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
514, 3oawA, 0.5255, 4.13, 0.039, 841, 102, 4-METHYLPTERIDINEONES AS ORALLY ACTIVE AND SELECTIVE PI3K/MTOR DUAL INHIBITORS
515, 3r7rA, 0.5254, 4.09, 0.040, 838, 100, STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3-KINASE
516, 5ul1A, 0.5253, 4.20, 0.020, 1000, 102, THE CO-STRUCTURE OF 3-AMINO-6-(4-((1-(DIMETHYLAMINO)PROPAN-2-YL) SULFONYL)PHENYL)-N-PHENYLPYRAZINE-2-CARBOXAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
517, 4kzcA, 0.5252, 3.99, 0.030, 821, 99, STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS
518, 3zvvA, 0.5252, 4.03, 0.030, 829, 99, FRAGMENT BOUND TO PI3KINASE GAMMA
519, 5t2iA, 0.5250, 4.10, 0.039, 820, 102, MPI3KD IN COMPLEX WITH 7K
520, 5sxiA, 0.5248, 3.96, 0.030, 1040, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 13
521, 4xz4A, 0.5248, 4.54, 0.051, 843, 99, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH AN INHIBITOR
522, 4ovvA, 0.5248, 3.87, 0.040, 1042, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH DIC4-PIP2
523, 1e8yA, 0.5248, 4.58, 0.051, 841, 99, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
524, 5t2mA, 0.5246, 3.95, 0.040, 820, 99, MPI3KD IN COMPLEX WITH 7M
525, 4ezkA, 0.5246, 4.11, 0.040, 842, 100, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
526, 3dpdA, 0.5245, 4.04, 0.050, 846, 101, ACHIEVING MULTI-ISOFORM PI3K INHIBITION IN A SERIES OF SUBSTITUTED 34-DIHYDRO-2H-BENZO[14]OXAZINES
527, 5nczA, 0.5239, 3.97, 0.030, 827, 100, MPI3KD IN COMPLEX WITH INH1
528, 1e8zA, 0.5239, 4.04, 0.040, 839, 99, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
529, 5swoA, 0.5237, 3.88, 0.040, 1050, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 4 AND 19
530, 3l13A, 0.5237, 4.09, 0.040, 841, 100, CRYSTAL STRUCTURES OF PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS
531, 2chwA, 0.5237, 4.09, 0.040, 840, 100, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110 ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-39
532, 5xgjA, 0.5236, 4.32, 0.010, 980, 102, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
533, 4l1bA, 0.5236, 4.23, 0.039, 994, 102, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA
534, 5sxbA, 0.5235, 4.09, 0.010, 1056, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 23
535, 5mwfB, 0.5235, 3.71, 0.031, 275, 96, HUMAN JAGGED2 C2-EGF2
536, 3hhmA, 0.5235, 4.03, 0.040, 1032, 101, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA AND THE DRUG WORTMANNIN
537, 4jpsA, 0.5234, 4.12, 0.030, 999, 101, CO-CRYSTAL STRUCTURES OF THE LIPID KINASE PI3K ALPHA WITH PAN AND ISOFORM SELECTIVE INHIBITORS
538, 3t8mA, 0.5234, 4.10, 0.020, 841, 99, RATIONAL DESIGN OF PI3K-ALPHA INHIBITORS THAT EXHIBIT SELECTIVITY OVER THE PI3K-BETA ISOFORM
539, 4ezlA, 0.5233, 4.01, 0.030, 834, 99, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
540, 3l16A, 0.5233, 4.10, 0.040, 841, 100, DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT SELECTIVE AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER
541, 5swpA, 0.5232, 4.01, 0.040, 1058, 101, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 6 AND 24
542, 4gb9A, 0.5231, 4.10, 0.040, 840, 100, POTENT AND HIGHLY SELECTIVE BENZIMIDAZOLE INHIBITORS OF PI3K-DELTA
543, 5oknE, 0.5230, 4.05, 0.049, 427, 103, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
544, 6audA, 0.5229, 4.09, 0.040, 840, 100, PI3K-GAMMA K802T IN COMPLEX WITH CPD 8 10-((1-(TERT-BUTYL)PIPERIDIN-4- YL)SULFINYL)-2-(1-ISOPROPYL-1H-124-TRIAZOL-5-YL)-56- DIHYDROBENZO[F]IMIDAZO[12-D][14]OXAZEPINE
545, 5sxdA, 0.5229, 3.92, 0.040, 1049, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 22
546, 5mwfF, 0.5229, 3.82, 0.153, 253, 98, HUMAN JAGGED2 C2-EGF2
547, 3l54A, 0.5229, 3.97, 0.030, 837, 99, STRUCTURE OF PI3K GAMMA WITH INHIBITOR
548, 5okmF, 0.5228, 4.12, 0.067, 433, 104, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
549, 3nzsA, 0.5228, 3.99, 0.051, 828, 99, STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE
550, 4j6iA, 0.5227, 4.00, 0.040, 833, 99, DISCOVERY OF THIAZOLOBENZOXEPIN PI3-KINASE INHIBITORS THAT SPARE THE PI3-KINASE BETA ISOFORM
551, 5okmE, 0.5226, 4.13, 0.048, 432, 104, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
552, 4f1sA, 0.5226, 4.12, 0.061, 834, 99, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL- TRIAZINE-SULFONAMIDE INHIBITOR
553, 1e7uA, 0.5226, 4.27, 0.040, 872, 101, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
554, 5oknF, 0.5225, 3.81, 0.060, 427, 100, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
555, 5dxuA, 0.5225, 4.03, 0.060, 922, 100, P110DELTA/P85ALPHA WITH GDC-0326
556, 2chzA, 0.5225, 4.04, 0.040, 839, 99, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-93
557, 5uk8A, 0.5223, 4.32, 0.039, 1008, 103, THE CO-STRUCTURE OF (R)-4-(6-(1-(CYCLOPROPYLSULFONYL)CYCLOPROPYL)-2- (1H-INDOL-4-YL)PYRIMIDIN-4-YL)-3-METHYLMORPHOLINE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
558, 4wwoA, 0.5223, 3.96, 0.052, 814, 97, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH PHENYLQUINOLINE INHIBITOR N-{(1S)-1-[8-CHLORO-2-(3-FLUOROPHENYL)QUINOLIN-3-YL]ETHYL}- 9H-PURIN-6-AMINE
559, 5mw5A, 0.5222, 3.68, 0.041, 258, 97, HUMAN JAGGED2 C2-EGF2
560, 4xlwH, 0.5221, 3.85, 0.051, 254, 99, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
561, 3cstA, 0.5221, 4.13, 0.040, 836, 100, CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR E5E2
562, 5g2nA, 0.5220, 4.02, 0.030, 823, 99, X-RAY STRUCTURE OF PI3KINASE GAMMA IN COMPLEX WITH COPANLISIB
563, 1e7vA, 0.5220, 4.56, 0.040, 850, 100, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
564, 5itdA, 0.5219, 4.13, 0.030, 995, 101, CRYSTAL STRUCTURE OF PI3K ALPHA WITH PI3K DELTA INHIBITOR
565, 5swtA, 0.5217, 4.15, 0.039, 1057, 102, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 17 AND 27
566, 5sxkA, 0.5215, 4.15, 0.039, 1053, 102, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 18
567, 5sx8A, 0.5215, 4.18, 0.039, 1052, 102, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 12 AND 15
568, 3ml8A, 0.5215, 4.21, 0.040, 843, 101, DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN
569, 5t2dA, 0.5214, 4.14, 0.039, 820, 102, MPI3KD IN COMPLEX WITH 7J
570, 4cc1B, 0.5214, 3.78, 0.043, 306, 94, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
571, 3qaqA, 0.5214, 4.22, 0.030, 837, 101, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 2 1
572, 4tuuA, 0.5213, 4.20, 0.049, 879, 102, ISOLATED P110A SUBUNIT OF PI3KA PROVIDES A PLATFORM FOR STRUCTURE- BASED DRUG DESIGN
573, 3l17A, 0.5213, 4.12, 0.040, 841, 100, DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT SELECTIVE AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER
574, 5jhaA, 0.5212, 4.05, 0.040, 803, 99, STRUCTURE OF PHOSPHOINOSITIDE 3-KINASE GAMMA (PI3K) BOUND TO THE POTENT INHIBITOR PIKIN2
575, 4tv3A, 0.5212, 4.20, 0.049, 879, 102, ISOLATED P110A SUBUNIT OF PI3KA PROVIDES A PLATFORM FOR STRUCTURE- BASED DRUG DESIGN
576, 4cc0A, 0.5212, 3.83, 0.054, 306, 93, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
577, 3apcA, 0.5212, 4.02, 0.061, 839, 98, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5132799
578, 4ezjA, 0.5209, 4.06, 0.040, 834, 99, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
579, 4cc0B, 0.5209, 3.79, 0.043, 267, 94, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
580, 5oknH, 0.5207, 4.14, 0.077, 430, 104, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
581, 5okmD, 0.5207, 3.90, 0.040, 436, 101, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
582, 4flhA, 0.5207, 4.20, 0.040, 840, 100, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH AMG511
583, 5oq4A, 0.5206, 4.06, 0.051, 834, 99, PQR309 - A POTENT BRAIN-PENETRANT ORALLY BIOAVAILABLE PAN-CLASS I PI3K/MTOR INHIBITOR AS CLINICAL CANDIDATE IN ONCOLOGY
584, 6ankA, 0.5205, 3.30, 0.092, 262, 87, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
585, 5swgA, 0.5205, 4.01, 0.030, 1041, 101, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 5 AND 21
586, 5sxfA, 0.5204, 3.92, 0.040, 1023, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 9
587, 5dxhD, 0.5204, 4.14, 0.030, 981, 100, P110ALPHA/P85ALPHA WITH COMPOUND 5
588, 5oknB, 0.5203, 4.12, 0.077, 431, 104, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
589, 5azxB, 0.5203, 2.99, 0.038, 99, 79, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
590, 4aofA, 0.5202, 4.00, 0.041, 836, 98, SELECTIVE SMALL MOLECULE INHIBITOR DISCOVERED BY CHEMOPROTEOMIC ASSAY PLATFORM REVEALS REGULATION OF TH17 CELL DIFFERENTIATION BY PI3KGAMMA
591, 5i6uA, 0.5201, 4.05, 0.030, 816, 101, THE CRYSTAL STRUCTURE OF PI3KDELTA WITH COMPOUND 32
592, 5sxeA, 0.5200, 3.93, 0.040, 1046, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 19 AND 28
593, 3dbsA, 0.5197, 4.08, 0.020, 841, 99, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH GDC0941
594, 1tjmA, 0.5196, 3.79, 0.098, 156, 92, CRYSTALLOGRAPHIC IDENTIFICATION OF SR2+ COORDINATION SITE IN SYNAPTOTAGMIN I C2B DOMAIN
595, 5oknA, 0.5195, 4.22, 0.067, 434, 105, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
596, 5azyB, 0.5195, 2.80, 0.039, 98, 77, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 2)
597, 5fi4A, 0.5193, 4.21, 0.049, 1009, 102, DISCOVERY OF IMIDAZO[12-A]-PYRIDINE INHIBITORS OF PAN-PI3 KINASES THAT ARE EFFICACIOUS IN A MOUSE XENOGRAFT MODEL
598, 3nzuA, 0.5193, 4.00, 0.041, 822, 98, STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE
599, 4xlwF, 0.5192, 3.82, 0.041, 252, 97, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
600, 4anvA, 0.5191, 4.51, 0.050, 848, 100, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
601, 4xl1E, 0.5190, 4.15, 0.060, 223, 100, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF1)
602, 4xlwD, 0.5188, 3.78, 0.081, 253, 99, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
603, 5uk5B, 0.5186, 4.00, 0.062, 299, 97, COMPLEX OF NOTCH1(EGF8-12) BOUND TO JAGGED1(N-EGF3)
604, 3qjzA, 0.5183, 4.07, 0.041, 795, 98, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH BENZOTHIAZOLE 1
605, 4ps7A, 0.5181, 4.02, 0.040, 843, 99, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH N-[6-(PYRIDIN-3-YL)-13- BENZOTHIAZOL-2-YL]ACETAMIDE
606, 5sx9A, 0.5180, 3.99, 0.040, 1044, 101, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 14
607, 4hvbA, 0.5180, 3.93, 0.052, 830, 97, CATALYTIC UNIT OF PI3KG IN COMPLEX WITH PI3K/MTOR DUAL INHIBITOR PF- 04979064
608, 5oknC, 0.5178, 4.20, 0.069, 421, 101, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
609, 3n5aA, 0.5178, 3.38, 0.091, 138, 88, SYNAPTOTAGMIN-7 C2B-DOMAIN CALCIUM BOUND
610, 5xghA, 0.5175, 4.15, 0.030, 993, 99, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
611, 4xx5A, 0.5175, 4.15, 0.041, 843, 98, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH AN INHIBITOR
612, 1w15A, 0.5173, 3.60, 0.157, 132, 89, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE PRESENCE OF CALCIUM
613, 5swrA, 0.5170, 4.12, 0.020, 1051, 99, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 20 AND 26
614, 4n8mA, 0.5170, 3.11, 0.063, 108, 79, STRUCTURAL POLYMORPHISM IN THE N-TERMINAL OLIGOMERIZATION DOMAIN OF NPM1
615, 4g11A, 0.5170, 4.17, 0.040, 836, 100, X-RAY STRUCTURE OF PI3K-GAMMA BOUND TO A 4-(MORPHOLIN-4-YL)- (6-OXO-1 6-DIHYDROPYRIMIDIN-2-YL)AMIDE INHIBITOR
616, 1uowA, 0.5170, 3.89, 0.108, 156, 93, CALCIUM BINDING DOMAIN C2B
617, 2r83A, 0.5169, 3.75, 0.099, 279, 91, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
618, 1tjxA, 0.5169, 3.89, 0.108, 156, 93, CRYSTALLOGRAPHIC IDENTIFICATION OF CA2+ COORDINATION SITES IN SYNAPTOTAGMIN I C2B DOMAIN
619, 4ps3A, 0.5168, 4.21, 0.030, 843, 99, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH 1-[6-(5-METHOXYPYRIDIN-3-YL)- 13-BENZOTHIAZOL-2-YL]-3-[2-(1-PROPYL-1H-IMIDAZOL-4-YL)ETHYL]UREA
620, 5t2gA, 0.5166, 4.05, 0.040, 820, 100, MPI3KD IN COMPLEX WITH 7I
621, 4xbmB, 0.5164, 3.80, 0.071, 401, 98, X-RAY CRYSTAL STRUCTURE OF NOTCH LIGAND DELTA-LIKE 1
622, 1e90A, 0.5163, 3.97, 0.051, 844, 98, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
623, 5ukjA, 0.5162, 4.25, 0.039, 1009, 102, THE CO-STRUCTURE OF NN-DIMETHYL-4-[(6R)-6-METHYL-5-(1H-PYRROLO[23- B]PYRIDIN-4-YL)-4567-TETRAHYDROPYRAZOLO[15- A]PYRAZIN-3- YL]BENZENESULFONAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
624, 4hleA, 0.5162, 4.11, 0.040, 828, 100, COMPOUND 21 (1-ALKYL-SUBSTITUTED 124-TRIAZOLES)
625, 2v4lA, 0.5160, 4.03, 0.041, 844, 97, COMPLEX OF HUMAN PHOSPHOINOSITIDE 3-KINASE CATALYTIC SUBUNIT GAMMA (P110 GAMMA) WITH PIK-284
626, 5mwfA, 0.5157, 3.85, 0.032, 276, 94, HUMAN JAGGED2 C2-EGF2
627, 1nlqE, 0.5153, 3.15, 0.063, 98, 79, THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING
628, 4ps8A, 0.5152, 4.04, 0.052, 843, 97, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH N-[6-(56-DIMETHOXYPYRIDIN-3- YL)-13-BENZOTHIAZOL-2-YL]ACETAMIDE
629, 3x0tA, 0.5147, 3.09, 0.122, 112, 82, CRYSTAL STRUCTURE OF PIRA
630, 5l73A, 0.5144, 3.53, 0.069, 174, 87, MAM DOMAIN OF HUMAN NEUROPILIN-1
631, 2yoaB, 0.5143, 3.56, 0.101, 149, 89, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
632, 3zw3A, 0.5140, 4.27, 0.030, 831, 100, FRAGMENT BASED DISCOVERY OF A NOVEL AND SELECTIVE PI3 KINASE INHIBITOR
633, 4l23A, 0.5138, 4.27, 0.021, 1014, 97, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND PI-103
634, 4fhkA, 0.5138, 3.98, 0.052, 819, 96, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDAZINE 19E
635, 5ccjB, 0.5137, 3.62, 0.101, 151, 89, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
636, 1xb9C, 0.5133, 3.40, 0.087, 104, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
637, 1nlqB, 0.5133, 3.24, 0.063, 97, 79, THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING
638, 5mw7A, 0.5130, 4.00, 0.031, 292, 97, HUMAN JAGGED2 C2-EGF3
639, 5kc2C, 0.5129, 4.27, 0.030, 783, 100, NEGATIVE STAIN STRUCTURE OF VPS15/VPS34 COMPLEX
640, 5dfzC, 0.5129, 4.27, 0.030, 783, 100, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
641, 6c1sA, 0.5127, 3.98, 0.052, 826, 96, PHOSPHOINOSITIDE 3-KINASE GAMMA BOUND TO AN PYRROLOPYRIDINONE INHIBITOR 
642, 5vfgA, 0.5126, 3.61, 0.101, 151, 89, SYNAPTOTAGMIN 1 C2B DOMAIN; LEAD-BOUND (HIGH OCCUPANCY) 
643, 1uovA, 0.5126, 3.59, 0.101, 149, 89, CALCIUM BINDING DOMAIN C2B
644, 5ccjA, 0.5125, 3.60, 0.101, 148, 89, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
645, 4zopA, 0.5125, 3.83, 0.093, 1000, 97, CO-CRYSTAL STRUCTURE OF LIPID KINASE PI3K ALPHA WITH A SELECTIVE PHOSPHATIDYLINOSITOL-3 KINASE ALPHA INHIBITOR
646, 4xl1B, 0.5124, 3.84, 0.051, 221, 98, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF1)
647, 5cciE, 0.5122, 3.68, 0.101, 280, 89, STRUCTURE OF THE MG2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
648, 4v11A, 0.5122, 3.63, 0.124, 150, 89, STRUCTURE OF SYNAPTOTAGMIN-1 WITH SV2A PEPTIDE PHOSPHORYLATED AT THR84
649, 5t8fA, 0.5120, 4.25, 0.030, 921, 100, P110DELTA/P85ALPHA WITH TASELISIB (GDC-0032)
650, 5ehdd, 0.5118, 3.16, 0.051, 107, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
651, 1xb9G, 0.5117, 3.43, 0.087, 105, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
652, 2rd0A, 0.5114, 4.28, 0.050, 997, 100, STRUCTURE OF A HUMAN P110ALPHA/P85ALPHA COMPLEX
653, 5vffA, 0.5113, 3.62, 0.101, 149, 89, SYNAPTOTAGMIN 1 C2B DOMAIN; LEAD-BOUND (LOW OCCUPANCY) 
654, 5ccjD, 0.5112, 3.61, 0.101, 152, 89, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
655, 1nlqA, 0.5111, 3.35, 0.075, 105, 80, THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING
656, 5kj8F, 0.5107, 3.72, 0.111, 274, 90, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
657, 1xe0A, 0.5107, 3.40, 0.087, 108, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
658, 5kj7F, 0.5105, 3.49, 0.102, 274, 88, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
659, 5ccgF, 0.5104, 3.52, 0.102, 274, 88, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
660, 4wafA, 0.5104, 4.28, 0.042, 1017, 96, CRYSTAL STRUCTURE OF A NOVEL TETRAHYDROPYRAZOLO[15-A]PYRAZINE IN AN ENGINEERED PI3K ALPHA
661, 2r83B, 0.5103, 3.90, 0.098, 279, 92, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
662, 4xlwB, 0.5101, 3.84, 0.071, 252, 99, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
663, 4e9kA, 0.5100, 3.40, 0.058, 237, 86, CRYSTAL STRUCTURE OF A DUF4465 FAMILY PROTEIN (BACOVA_04221) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.31 A RESOLUTION
664, 2yoaA, 0.5100, 3.59, 0.101, 149, 89, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
665, 4fhjA, 0.5099, 4.00, 0.042, 819, 96, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDINE 2
666, 5ehdb, 0.5097, 3.37, 0.050, 105, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
667, 5ccjC, 0.5096, 3.64, 0.101, 148, 89, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
668, 5t0sA, 0.5095, 3.70, 0.111, 151, 90, SYNAPTOTAGMIN 1 C2B DOMAIN CADMIUM-BOUND
669, 5ehda, 0.5095, 3.07, 0.051, 106, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
670, 1xe0B, 0.5094, 3.41, 0.087, 107, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
671, 3zimA, 0.5091, 4.11, 0.030, 886, 99, DISCOVERY OF A POTENT AND ISOFORM-SELECTIVE TARGETED COVALENT INHIBITOR OF THE LIPID KINASE PI3KALPHA
672, 1nlqC, 0.5091, 3.24, 0.064, 96, 78, THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING
673, 5ehdi, 0.5090, 3.34, 0.050, 107, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
674, 1xe0I, 0.5090, 3.36, 0.087, 105, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
675, 5ehdG, 0.5089, 3.34, 0.050, 106, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
676, 5ccgE, 0.5089, 3.51, 0.102, 278, 88, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
677, 1xe0F, 0.5089, 3.42, 0.087, 108, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
678, 1xb9B, 0.5087, 3.36, 0.087, 107, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
679, 5sxcA, 0.5086, 4.32, 0.040, 1038, 100, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 8
680, 5kj8E, 0.5085, 3.57, 0.102, 278, 88, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
681, 5kj7E, 0.5084, 3.67, 0.101, 278, 89, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
682, 5ehdH, 0.5083, 3.34, 0.050, 107, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
683, 5xgiA, 0.5082, 4.34, 0.030, 1013, 100, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
684, 3l08A, 0.5081, 4.09, 0.041, 828, 98, STRUCTURE OF PI3K GAMMA WITH A POTENT INHIBITOR: GSK2126458
685, 1xb9E, 0.5081, 3.44, 0.087, 106, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
686, 5cchE, 0.5080, 3.66, 0.101, 280, 89, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
687, 4n8mE, 0.5076, 3.21, 0.051, 106, 79, STRUCTURAL POLYMORPHISM IN THE N-TERMINAL OLIGOMERIZATION DOMAIN OF NPM1
688, 2p1bI, 0.5075, 3.07, 0.051, 100, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
689, 5jhbA, 0.5073, 4.13, 0.020, 811, 98, STRUCTURE OF PHOSPHOINOSITIDE 3-KINASE GAMMA (PI3K) BOUND TO THE POTENT INHIBITOR PIKIN3
690, 5w5dF, 0.5072, 3.63, 0.101, 152, 89, CRYSTAL STRUCTURE OF THE PRIMED SNARE-COMPLEXIN-SYNAPTOTAGMIN-1 C2B COMPLEX
691, 2p1bE, 0.5072, 3.23, 0.051, 100, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
692, 2p1bG, 0.5071, 3.20, 0.051, 100, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
693, 1xb9J, 0.5069, 3.27, 0.089, 106, 79, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
694, 2p1bC, 0.5068, 3.08, 0.051, 100, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
695, 2p1bA, 0.5068, 3.06, 0.051, 100, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
696, 5ccgK, 0.5067, 3.56, 0.102, 278, 88, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
697, 5kj8K, 0.5065, 3.54, 0.102, 278, 88, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
698, 2enjA, 0.5063, 3.71, 0.066, 138, 91, SOLUTION STURCTURE OF THE C2 DOMAIN FROM HUMAN PROTEIN KINASE C THETA
699, 1bdyA, 0.5063, 3.81, 0.075, 123, 93, C2 DOMAIN FROM PROTEIN KINASE C DELTA
700, 5l73B, 0.5062, 3.61, 0.080, 174, 87, MAM DOMAIN OF HUMAN NEUROPILIN-1
701, 2p1bD, 0.5061, 3.10, 0.051, 100, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
702, 5kj7K, 0.5060, 3.56, 0.102, 278, 88, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
703, 2v5yA, 0.5058, 3.45, 0.103, 564, 87, CRYSTAL STRUCTURE OF THE RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU ECTODOMAIN
704, 1xb9I, 0.5055, 3.31, 0.089, 107, 79, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
705, 4n8mD, 0.5054, 3.31, 0.050, 105, 80, STRUCTURAL POLYMORPHISM IN THE N-TERMINAL OLIGOMERIZATION DOMAIN OF NPM1
706, 2p1bJ, 0.5053, 3.07, 0.051, 100, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
707, 1xb9F, 0.5052, 3.43, 0.087, 105, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
708, 1xe0E, 0.5051, 3.34, 0.089, 104, 79, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
709, 5ehdE, 0.5048, 3.12, 0.051, 106, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
710, 1w16A, 0.5048, 3.56, 0.071, 125, 84, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE ABSENCE OF CALCIUM
711, 2p1bH, 0.5043, 3.11, 0.051, 100, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
712, 3zhnA, 0.5041, 3.96, 0.068, 131, 88, CRYSTAL STRUCTURE OF THE T6SS LIPOPROTEIN TSSJ1 FROM PSEUDOMONAS AERUGINOSA
713, 3rx9A, 0.5041, 3.54, 0.081, 130, 86, 3D STRUCTURE OF SCIN FROM AN ESCHERICHIA COLI PATOTYPE
714, 5ehdF, 0.5035, 3.30, 0.050, 107, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
715, 2p1bB, 0.5034, 3.15, 0.051, 100, 78, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
716, 5lobC, 0.5033, 3.52, 0.057, 138, 87, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
717, 1bdyB, 0.5033, 3.80, 0.065, 123, 92, C2 DOMAIN FROM PROTEIN KINASE C DELTA
718, 5ehdh, 0.5032, 3.26, 0.050, 106, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
719, 4a1rB, 0.5032, 3.77, 0.115, 140, 87, THE STRUCTURE OF SERRATIA MARCESCENS LIP A MEMBRANE BOUND COMPONENT OF THE TYPE VI SECRETION SYSTEM.
720, 1k5wA, 0.5032, 3.71, 0.101, 148, 89, THREE-DIMENSIONAL STRUCTURE OF THE SYNAPTOTAGMIN 1 C2B- DOMAIN: SYNAPTOTAGMIN 1 AS A PHOSPHOLIPID BINDING MACHINE
721, 1xb9H, 0.5031, 3.46, 0.087, 107, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
722, 5cciF, 0.5029, 3.71, 0.090, 268, 89, STRUCTURE OF THE MG2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
723, 4a1rA, 0.5029, 3.83, 0.112, 142, 89, THE STRUCTURE OF SERRATIA MARCESCENS LIP A MEMBRANE BOUND COMPONENT OF THE TYPE VI SECRETION SYSTEM.
724, 4a1rC, 0.5028, 3.73, 0.128, 137, 86, THE STRUCTURE OF SERRATIA MARCESCENS LIP A MEMBRANE BOUND COMPONENT OF THE TYPE VI SECRETION SYSTEM.
725, 1xe0G, 0.5028, 3.31, 0.089, 104, 79, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
726, 5ehdB, 0.5027, 3.30, 0.050, 105, 80, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
727, 4y7oC, 0.5027, 3.66, 0.081, 123, 86, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (869-1107) FROM EAEC
728, 5ehdj, 0.5024, 3.17, 0.051, 106, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
729, 1yrkA, 0.5024, 3.79, 0.065, 126, 92, THE C2 DOMAIN OF PKC<DELTA> IS A NEW PHOSPHO-TYROSINE BINDING DOMAIN
730, 5w4sA, 0.5022, 3.83, 0.105, 139, 86, SOLUTION STRUCTURE OF C2 DOMAIN FROM PROTEIN KINASE C ALPHA IN TERNARY COMPLEX WITH CALCIUM AND V5-PHM PEPTIDE 
731, 5ehdc, 0.5022, 3.14, 0.051, 106, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
732, 1xb9A, 0.5021, 3.34, 0.089, 108, 79, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE CHAPERONE IN THE NUCLEOLUS
733, 2cm6B, 0.5018, 3.82, 0.056, 148, 89, CRYSTAL STRUCTURE OF THE C2B DOMAIN OF RABPHILIN3A
734, 5sw8A, 0.5015, 4.48, 0.050, 1030, 101, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 7 AND 11
735, 3f00A, 0.5015, 3.45, 0.116, 142, 86, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN I C2A DOMAIN WITH CU(II)
736, 4ldcA, 0.5013, 3.63, 0.068, 149, 88, CRYSTAL STRUCTURE OF DOC2B C2B DOMAIN
737, 5ehdD, 0.5012, 3.18, 0.051, 105, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
738, 4a42B, 0.5012, 2.76, 0.078, 125, 77, CPGH89CBM32-6 PRODUCED BY CLOSTRIDIUM PERFRINGENS
739, 4a42A, 0.5011, 2.78, 0.078, 126, 77, CPGH89CBM32-6 PRODUCED BY CLOSTRIDIUM PERFRINGENS
740, 5ehdg, 0.5010, 3.18, 0.051, 106, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
741, 2n1tE, 0.5010, 3.73, 0.101, 156, 89, DYNAMIC BINDING MODE OF A SYNAPTOTAGMIN-1-SNARE COMPLEX IN SOLUTION
742, 5lobB, 0.5009, 3.56, 0.057, 139, 87, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
743, 5ehdJ, 0.5009, 3.19, 0.051, 107, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
744, 1xe0J, 0.5009, 3.33, 0.087, 104, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
745, 5sv5A, 0.5008, 2.89, 0.105, 103, 76, 1.0 ANGSTROM CRYSTAL STRUCTURE OF PRE-PEPTIDASE C-TERMINAL DOMAIN OF COLLAGENASE FROM BACILLUS ANTHRACIS.
746, 5lowA, 0.5007, 3.47, 0.058, 142, 86, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
747, 5ehdA, 0.5007, 3.18, 0.051, 106, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
748, 2p1bF, 0.5007, 3.15, 0.051, 100, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE
749, 1xe0H, 0.5007, 3.35, 0.087, 104, 80, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
750, 5ehdC, 0.5004, 3.18, 0.051, 107, 79, CRYSTAL STRUCTURE OF HUMAN NUCLEOPHOSMIN-CORE IN COMPLEX WITH CYTOCHROME C
751, 1xe0D, 0.5003, 3.37, 0.089, 105, 79, THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS
752, 3x0tB, 0.5002, 2.96, 0.128, 108, 78, CRYSTAL STRUCTURE OF PIRA
753, 3f01A, 0.5002, 3.46, 0.116, 143, 86, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN I C2A DOMAIN WITH CU(II)
754, 1dqvA, 0.5001, 3.75, 0.067, 275, 89, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN III C2A/C2B
